Choline Quantification in Breast Cancer by MRS

Breast Neoplasms Clinical Trial

Official title: Choline Quantification in Breast Cancer by MRS

Status Withdrawn

Clinical Trial Summary

Choline has been found in increased concentration in breast cancer patients. Hypothesis: The choline signal as observed by MRS is sensitive to treatment, and a positive response to treatment will give a reduction in choline concentration.

The purpose of this study is to establish methods for quantification of choline in breast cancer by MRS

Clinical Trial Description

1. Establishment of new MRS sequence for choline quantification of choline. This sequence is choline-selective, and signals from water and lipids are suppressed simultaneously.

2. Compare to different methods for choline quantification. The first method is quantification through an external phantom standard, containing a known concentration of choline. The other method is based on the utilisation of internal water signal as a reference.

Both calculations can be performed from the same MR exam. Ten patients will be included in the study. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Breast Neoplasms

• NCT number: NCT00201487
• Study type: Observational
• Source: Norwegian University of Science and Technology
• Status: Withdrawn
• Phase: N/A
• Start date: November 2007
• Completion date: November 2007